^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Tedopi (OSE 2101)

    i
    Company:
    Chong Kun Dang, OSE Immunotherapeutics
    Drug class:
    Immunostimulant
    Related drugs:
    Apply
    Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPAM) (NCT03806309)
    Phase 2
    GERCOR - Multidisciplinary Oncology Cooperative...
    Recruiting
    Last update posted :
    02/27/2023
    Initiation :
    07/31/2019
    Primary completion :
    12/30/2023
    Completion :
    12/30/2024
    UGT1A1
    |
    UGT1A1*1*1
    |
    Opdivo (nivolumab) • 5-fluorouracil • oxaliplatin • irinotecan • leucovorin calcium • Tedopi (OSE 2101)